Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR in Schizophrenia with Cannabis Abuse
NCT01071135Phase 3Terminated
- Sponsor
- Hannover Medical School
- Start
- Sep 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in schizophrenia, cannabis-induced psychotic disorder (CIPD), sponsored by Hannover Medical School. Started Sep 2009; status: terminated.
02
Drugs
quetiapine
03
Conditions
schizophreniacannabis-induced psychotic disorder (CIPD)
Beyond the preview
Go deeper on NCT01071135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01071135.